ReWalk Robotics (NASDAQ:RWLK) Shares Pass Above Fifty Day Moving Average of $1.11

ReWalk Robotics Ltd. (NASDAQ:RWLKGet Rating)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.11 and traded as high as $1.13. ReWalk Robotics shares last traded at $1.09, with a volume of 274,046 shares traded.

A number of brokerages recently commented on RWLK. StockNews.com began coverage on ReWalk Robotics in a report on Thursday, March 31st. They set a “sell” rating on the stock. Zacks Investment Research lowered ReWalk Robotics from a “hold” rating to a “sell” rating in a research note on Wednesday, March 2nd.

The stock has a market capitalization of $68.13 million, a P/E ratio of -4.04 and a beta of 2.90. The company has a 50 day simple moving average of $1.11 and a 200-day simple moving average of $1.23.

ReWalk Robotics (NASDAQ:RWLKGet Rating) last issued its earnings results on Thursday, February 24th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.02). The firm had revenue of $1.24 million during the quarter, compared to the consensus estimate of $1.79 million. ReWalk Robotics had a negative net margin of 213.48% and a negative return on equity of 16.05%. During the same quarter in the previous year, the firm earned ($0.14) earnings per share. As a group, equities research analysts anticipate that ReWalk Robotics Ltd. will post -0.21 earnings per share for the current year.

In related news, major shareholder Global Fund Lp Lind II purchased 395,009 shares of ReWalk Robotics stock in a transaction dated Thursday, February 24th. The stock was bought at an average cost of $1.03 per share, for a total transaction of $406,859.27. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders bought 619,597 shares of company stock valued at $638,635. 0.44% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of RWLK. CVI Holdings LLC purchased a new position in shares of ReWalk Robotics in the 3rd quarter worth about $896,000. Advisor Group Holdings Inc. boosted its holdings in shares of ReWalk Robotics by 76.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 925,332 shares of the medical device company’s stock worth $1,138,000 after purchasing an additional 402,225 shares in the last quarter. Millennium Management LLC purchased a new position in shares of ReWalk Robotics in the 4th quarter worth about $280,000. Goldman Sachs Group Inc. boosted its holdings in shares of ReWalk Robotics by 150.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 100,224 shares of the medical device company’s stock worth $123,000 after purchasing an additional 60,257 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of ReWalk Robotics in the 3rd quarter worth about $89,000. Institutional investors and hedge funds own 12.31% of the company’s stock.

ReWalk Robotics Company Profile (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

Read More

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.